The Rh(ii)-catalyzed sulfur ylide [1,2]-rearrangement of carbenoids generated from aryldiazoacetates has been realized via N-S bond insertion, generating tertiary sulfides in moderate to excellent yields. This demonstrates the first use of the sulfur ylide [1,2]-rearrangement undergoing N-S bond insertion. This protocol could proceed smoothly with high regioselectivity, low catalyst loading (0.1 mol% Rh2(OAc)4), gram-scale reaction and broad substrate scope. And the product could be converted into glycine derivatives through simple procedures.
A practical and efficient stereoselective synthesis of arylglycine derivatives was realized via palladium-catalyzed α-arylation of a chiral nickel(II) glycinate complex with aryl bromides. The structurally diverse arylglycine products were obtained in excellent isolated yields and with good diastereoselectivity. A simple acidic hydrolysis furnished optically pure arylglycines in high yield, and the chiral ligand (S)-BPB could be efficiently recovered and reused.
Stereoselective Synthesis of Arylglycine Derivatives via Palladium-Catalyzed -Arylation of a Chiral Nickel(II) Glycinate. -Structurally diverse aryl bromides are well tolerated in the -arylation reaction with a chiral nickel(II) glycinate complex. The diastereoisomerically pure nickel(II) arylglycine complexes can be converted to non-naturally occurring arylglycines in high yields and enantiomeric excess. The chiral auxiliary can be recovered and reused. -(ZHANG, F.; SUN, H.; SONG, Z.; ZHOU, S.; WEN, X.; XU, Q.-L.; SUN*, H.; J. Org. Chem. 80 (2015) 9, 4459-4464, http://dx.doi.org/10.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.